SHELLEY BYRD: Open Payments
NPI 1841576915 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$993 in 49 payments from 13 companies in 2025. Trend: 2023 $1,019 · 2024 $755 · 2025 $993
Food & beverage: $993
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $238 |
| AstraZeneca Pharmaceuticals LP | 9 | $186 |
| PFIZER INC. | 3 | $117 |
| Amgen Inc. | 4 | $91 |
| Novo Nordisk Inc | 4 | $82 |
| Exact Sciences Corporation | 4 | $71 |
| Lilly USA, LLC | 3 | $55 |
| Phathom Pharmaceuticals, Inc. | 1 | $36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $32 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $24 |
Products named: VRAYLAR, FARXIGA, UBRELVY, NURTEC ODT, Cologuard Collection Kit, KRYSTEXXA, Rybelsus, MOUNJARO.
Industry payments across AL — which companies pay providers there.
